Monitoring of sirolimus in the whole blood samples from pediatric patients with lymphatic anomalies

In recent years, off-label use of sirolimus (SIR) has been gaining attention in the clinical practice. However, since it is critical to achieve and maintain therapeutic blood levels of SIR during treatment, the regular monitoring of this drug in individual patients must be implemented, especially in...

Descripción completa

Detalles Bibliográficos
Autores principales: Treder, Natalia, Plenis, Alina, Maliszewska, Olga, Kaczmarczyk, Natalia, Olędzka, Ilona, Kowalski, Piotr, Bączek, Tomasz, Bień, Ewa, Krawczyk, Małgorzata Anna, Roszkowska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982740/
https://www.ncbi.nlm.nih.gov/pubmed/36874365
http://dx.doi.org/10.1515/med-2023-0652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982740/
https://www.ncbi.nlm.nih.gov/pubmed/36874365
http://dx.doi.org/10.1515/med-2023-0652

Ejemplares similares